The company is still seeking a judicial stay pending the outcome of its lawsuit. Read More
Tags :U.S. Food and Drug Administration
Judges say the FDA pulled a “surprise switcheroo” in changing its PMTA guidance.Read More
The move suggests the earlier rescission of TBP’s MDO was not a one-off. Read More
It remains unclear whether the FDA will withdraw more marketing denials.Read More
Altria discontinued its Verven oral tobacco product three years ago. Read More
It could be some time before the FDA issues marketing orders for flavored vapor products.Read More
The candidate’s experience includes regulation of tobacco and medical products. Read More
Also in TR
Derek Yach
Featured
Harm Reduction
News This Week
‘Vuse Authorization a Positive for Harm Reduction’
Derek Yach urges governments to ‘follow the science.’Read More
This marks the first set of ENDS products ever to be authorized through the PMTA pathway. Read More
The company’s marketing application was not properly assessed, says FDA.Read More
